Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy.


Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 5 3 2020
medline: 5 3 2020
entrez: 5 3 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 32127717
doi: 10.1038/s41587-020-0461-z
pii: 10.1038/s41587-020-0461-z
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

503

Commentaires et corrections

Type : ErratumFor

Auteurs

Greta Giordano-Attianese (G)

Ludwig Institute for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland.
Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Pablo Gainza (P)

Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.

Elise Gray-Gaillard (E)

Ludwig Institute for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland.
Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Elisabetta Cribioli (E)

Ludwig Institute for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland.
Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Sailan Shui (S)

Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.

Seonghoon Kim (S)

Department of Biological Sciences, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.

Mi-Jeong Kwak (MJ)

Department of Biological Sciences, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.

Sabrina Vollers (S)

Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.

Angel De Jesus Corria Osorio (AJ)

Ludwig Institute for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland.
Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Patrick Reichenbach (P)

Ludwig Institute for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland.
Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Jaume Bonet (J)

Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.

Byung-Ha Oh (BH)

Department of Biological Sciences, Institute for the Biocentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.

Melita Irving (M)

Ludwig Institute for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland. melita.irving@unil.ch.
Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. melita.irving@unil.ch.

George Coukos (G)

Ludwig Institute for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland. george.coukos@unil.ch.
Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. george.coukos@unil.ch.

Bruno E Correia (BE)

Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. bruno.correia@epfl.ch.
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland. bruno.correia@epfl.ch.

Classifications MeSH